The role of (18)F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy

PURPOSE: To investigate the diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET), as an imaging biomarker, for predicting pathological response and prognosis of unresectable hepatocellular carcinoma (HCC) patients treated with Lenvatinib and programmed cell death...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guanyun, Zhang, Wenwen, Luan, Xiaohui, Wang, Zhanbo, Liu, Jiajin, Xu, Xiaodan, Zhang, Jinming, Xu, Baixuan, Lu, Shichun, Wang, Ruimin, Ma, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196479/
https://www.ncbi.nlm.nih.gov/pubmed/37215117
http://dx.doi.org/10.3389/fimmu.2023.1151967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196479/
https://www.ncbi.nlm.nih.gov/pubmed/37215117
http://dx.doi.org/10.3389/fimmu.2023.1151967

Ejemplares similares